1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity>99.0% (HPLC)
Mugadziri Wekugovera Vepakati veAripiprazole NeKuchena Kwakanyanya
Aripiprazole API CAS 129722-12-9
1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7-(4-Bromobutoxy)-3,4-Dihydro-2(1H)-Quinolinone CAS 129722-34-5
Chemical Name | 1-(2,3-Dichlorophenyl)piperazine Hydrochloride |
Mashoko anoreva zvakafanana | 2,3-DCPP HCl;1-(2,3-Dichlorophenyl)piperazine HCl;Aripiprazole EP Kusachena B;Aripiprazole Related Compound C |
Nhamba yeCAS | 119532-26-2 |
Nhamba yeCAT | RF-PI2268 |
Stock Status | MuStock, Kukwanisa Kugadzira 30 MT/Mwedzi |
Molecular Formula | C10H12Cl2N2·HCl |
Molecular Weight | 267.58 |
Melting Point | 245.0~247.0℃ |
Kuchengeta & Sensitivity | Hygroscopic.Ambient tembiricha |
Solubility mumvura | Soluble mumvura |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | White kana Off-White Powder |
Kuchena / Analysis Method | >99.0% (HPLC) |
Kurasika paKuomesa | <0.50% |
Residue paIgnition | <0.10% |
Kusachena Kumwechete | <0.50% |
Zvose Zvisina Kuchena | <1.00% |
Heavy Metals (as Pb) | ≤20ppm |
Infrared Spectrum | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Usage | Pakati peAripiprazole (CAS: 129722-12-9) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Hygroscopic.Chengetedza kure nemvura / unyoro uye oxidizing agents.Chengetedza mudziyo wakavharwa zvakasimba woiisa munzvimbo inotonhorera, yakaoma uye ine mhepo yakanaka.Chengetedza pasi pegesi inert
1-(2,3-Dichlorophenyl)piperazine Hydrochloride (CAS: 119532-26-2) inokosha yepakati yeAripiprazole (CAS: 129722-12-9).Aripiprazole rudzi rutsva rwezvakanyanya lipid soluble quinoline derivatives, iyo pharmacological mhedzisiro hunhu ndeyekuti haisi chete postsynaptic dopamine D 2 receptor antagonist, asiwo presynaptic dopamine D 2 receptor agonist, inogona zvakare kufadza D 1, D 3, D 4 receptors;ine huviri mhedzisiro yekusarudzika activation kana receptor antagonistic pa5-HT 1A receptor;ine chiito chinopesana zvachose pane 5-HT 2A receptor.Ichi chimiro chakasiyana nechizvarwa chekutanga, uye atypical antipsychotics inova yechizvarwa chechipiri antipsychotic mishonga, uye nekudaro inonzi dopamine system stabilizer kana yechitatu chizvarwa antipsychotic.Sezvo ichitengeswa mumusika, inonyanya kushandiswa mukiriniki schizophrenia, kurapwa kweanokanganisa kusagadzikana uye zvimwe zvirwere zvepfungwa.Zvinoenderana nemabhuku, aripiprazole ine zvakakosha mhedzisiro pane schizophrenia yakanaka uye yakaipa zviratidzo uye kusagadzikana, kushushikana, kugona kwekuziva, nepo kuchengetedzwa kwepamusoro.Zvakataurwawo kuti mushonga unogona kurapa zvimwe zvirwere zvepfungwa, zvakadai sezvinyamusi manic episodes, senile dementia yakabatana nekukanganisika kwepfungwa, kusagadzikana kwekuzvidya mwoyo, maitiro evana, kuora mwoyo.Mazuva ano, Bristol-Myers Squibb neOtsuka Pharmaceutical Company yakazivisa kuti European Union yakabvumidza Abilify (aripiprazole) mukurapa schizophrenia rondedzero application.